Advancements in Tumor Immunotherapy and Cancer Vaccines / / Hilal Arnouk, editor.
Harnessing the potential of the human body's own immune system to attack malignant tumor cells has been the goal of many scientific investigators in recent years, with advances in cancer biology and immunology enabling cancer immunotherapy to become a reality. World-class bench and clinical res...
Saved in:
| TeilnehmendeR: | |
|---|---|
| Place / Publishing House: | Rijeka, Croatia : : InTech,, [2012] ©2012 |
| Year of Publication: | 2012 |
| Language: | English |
| Physical Description: | 1 online resource (vi, 218 pages) :; illustrations |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993547886504498 |
|---|---|
| ctrlnum |
(CKB)3230000000075386 (NjHacI)993230000000075386 (oapen)https://directory.doabooks.org/handle/20.500.12854/65519 (EXLCZ)993230000000075386 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Arnouk, Hilal edt Advancements in Tumor Immunotherapy and Cancer Vaccines / Hilal Arnouk, editor. IntechOpen 2012 Rijeka, Croatia : InTech, [2012] ©2012 1 online resource (vi, 218 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on: online resource; title from PDF information screen (InTech, viewed October 14, 2022). Includes bibliographical references and index. Open access Unrestricted online access star Harnessing the potential of the human body's own immune system to attack malignant tumor cells has been the goal of many scientific investigators in recent years, with advances in cancer biology and immunology enabling cancer immunotherapy to become a reality. World-class bench and clinical researchers have joined forces to collaborate and review current developments and trends in cancer immunology for the purposes of this book, and the result is a promising review of contemporary clinical treatments. In each chapter the authors present the scientific basis behind such therapeutic approaches, including cancer vaccines with special focus on prostate cancer, melanoma and novel approaches utilizing both innate and adaptive immune responses. English Cancer vaccines. Oncology 953-307-998-3 Arnouk, Hilal, editor. |
| language |
English |
| format |
eBook |
| author2 |
Arnouk, Hilal, |
| author_facet |
Arnouk, Hilal, |
| author2_variant |
h a ha h a ha |
| author2_role |
TeilnehmendeR |
| title |
Advancements in Tumor Immunotherapy and Cancer Vaccines / |
| spellingShingle |
Advancements in Tumor Immunotherapy and Cancer Vaccines / |
| title_full |
Advancements in Tumor Immunotherapy and Cancer Vaccines / Hilal Arnouk, editor. |
| title_fullStr |
Advancements in Tumor Immunotherapy and Cancer Vaccines / Hilal Arnouk, editor. |
| title_full_unstemmed |
Advancements in Tumor Immunotherapy and Cancer Vaccines / Hilal Arnouk, editor. |
| title_auth |
Advancements in Tumor Immunotherapy and Cancer Vaccines / |
| title_new |
Advancements in Tumor Immunotherapy and Cancer Vaccines / |
| title_sort |
advancements in tumor immunotherapy and cancer vaccines / |
| publisher |
IntechOpen InTech, |
| publishDate |
2012 |
| physical |
1 online resource (vi, 218 pages) : illustrations |
| isbn |
953-51-6788-X 953-307-998-3 |
| callnumber-first |
R - Medicine |
| callnumber-subject |
RC - Internal Medicine |
| callnumber-label |
RC271 |
| callnumber-sort |
RC 3271 I45 A383 42012 |
| illustrated |
Illustrated |
| dewey-hundreds |
600 - Technology |
| dewey-tens |
610 - Medicine & health |
| dewey-ones |
616 - Diseases |
| dewey-full |
616.99406 |
| dewey-sort |
3616.99406 |
| dewey-raw |
616.99406 |
| dewey-search |
616.99406 |
| work_keys_str_mv |
AT arnoukhilal advancementsintumorimmunotherapyandcancervaccines |
| status_str |
n |
| ids_txt_mv |
(CKB)3230000000075386 (NjHacI)993230000000075386 (oapen)https://directory.doabooks.org/handle/20.500.12854/65519 (EXLCZ)993230000000075386 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Advancements in Tumor Immunotherapy and Cancer Vaccines / |
| author2_original_writing_str_mv |
noLinkedField |
| _version_ |
1787551938648211456 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02134nam a2200409 i 4500</leader><controlfield tag="001">993547886504498</controlfield><controlfield tag="005">20230811163511.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr#|||||||||||</controlfield><controlfield tag="008">221015s2012 ci a ob 001 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-6788-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3230000000075386</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)993230000000075386</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/65519</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993230000000075386</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC271.I45</subfield><subfield code="b">.A383 2012</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.99406</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Arnouk, Hilal</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Advancements in Tumor Immunotherapy and Cancer Vaccines /</subfield><subfield code="c">Hilal Arnouk, editor.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2012</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Rijeka, Croatia :</subfield><subfield code="b">InTech,</subfield><subfield code="c">[2012]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (vi, 218 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (InTech, viewed October 14, 2022).</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Harnessing the potential of the human body's own immune system to attack malignant tumor cells has been the goal of many scientific investigators in recent years, with advances in cancer biology and immunology enabling cancer immunotherapy to become a reality. World-class bench and clinical researchers have joined forces to collaborate and review current developments and trends in cancer immunology for the purposes of this book, and the result is a promising review of contemporary clinical treatments. In each chapter the authors present the scientific basis behind such therapeutic approaches, including cancer vaccines with special focus on prostate cancer, melanoma and novel approaches utilizing both innate and adaptive immune responses.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer vaccines.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Oncology</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">953-307-998-3</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arnouk, Hilal,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-08-12 05:06:56 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2012-12-09 08:17:33 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338638570004498&Force_direct=true</subfield><subfield code="Z">5338638570004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338638570004498</subfield></datafield></record></collection> |